Submitted by Anonymous (not verified) on 4 October 2023 - 14:47
Human medicines European public assessment report (EPAR): Cholib, fenofibrate,simvastatin, Dyslipidemias, Date of authorisation: 26/08/2013, Revision: 16, Status: Authorised
Source: